|
BJDX Bluejay Diagnostics Inc 1704287 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-2,324,013.00 |
| Balance Sheet |
|
Current Assets
|
$9,814,952.00 |
|
Assets
|
$11,533,900.00 |
|
Current Liabilities
|
$2,116,641.00 |
|
Liabilities
|
$2,119,060.00 |
|
Equity
|
$9,414,840.00 |
|
Shares Out
|
1983684.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,088,556.00 |
|
Investing Cash Flow
|
$-158,087.00 |
| Market Analysis |
Market Cap
|
$1,864,662.96 |
|
Price
|
$0.94 |
|
BVPS
|
4.75 |
|
PB
|
0.20 |
|
EPS
|
-1.12 |
|
FCF
|
$-3,250,318.00 |
|
| Dividends |
|
Dividend Amount
|
2.15 |
|
Dividend Data Last Updated
|
2026-09-01 09:33:03 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BJDX documents filed with the SEC.
BJDX Filings
Clear
